Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • India recalls rabies...

    India recalls rabies vaccines made by tainted China firm

    Written by Ruby Khatun Khatun Published On 2018-08-02T10:00:10+05:30  |  Updated On 2 Aug 2018 10:00 AM IST
    India recalls rabies vaccines made by tainted China firm




    India has ordered an immediate recall of rabies vaccines made by a scandal-hit Chinese company, India's drug regulator said Wednesday, complaining it only found out about possible problems through media reports.

    S. Eswara Reddy, the drug controller general said that it has also put a temporary stop on fresh imports of the vaccine made by Changchun Changsheng after it emerged that it had fabricated records, in the latest product safety scare to rock China.

    "We have stopped the import of the rabies vaccines for the time being. An investigation is going on and till then the import is prohibited," Reddy said.

    "Whatever vaccines were already imported they are being recalled. As per law, the import license holder should have informed us if there was a problem with the overseas supplier but he did not inform us."

    Rabies kills an estimated 20,000 people in India every year, according to the government's National Rabies Control Programme.

    China's latest product-safety scandal emerged more than a week ago with news that Changchun Changsheng Biotechnology was ordered to cease production of its rabies vaccines.

    The Chinese government has said the suspect vaccine did not enter the market, but there are fears the sub-standard vaccines may have been imported not only to India but also Cambodia and Egypt.

    The World Health Organization's office in China said it did not have information on which countries may have imported the vaccine.

    But its staff "had seen evidence that a domestic and foreign recall of the affected vaccine was initiated in mid-July", WHO said in an email reply to AFP.

    The vaccine case has provoked unusually strong outrage from Chinese consumers fed up with recurring safety scandals.

    Parents have vented anger online, prompting the ruling Communist Party's internet censors to swoop in and purge mention of the issue.

    The anger was exacerbated by the additional revelation that Changsheng's vaccine for diphtheria, pertussis, and tetanus (DPT) had also failed to meet quality standards, but that 250,000 doses were nonetheless sold last year.

    China is regularly hit by scandals involving unsafe food, drugs or other products despite repeated official promises to root out the corruption and shoddy manufacturing that is usually blamed.



    Changchun ChangshengChina firmDCGIdiphtheriaDPTDrug Controller General of IndiaIndiaNational Rabies Control Programmepertussisrabies vaccinesrecallsS Eswara Reddytetanus
    Source : AFP

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok